Clinical and Subclinical Macrovascular Disease as Predictors of Cognitive Decline in Older Patients With Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Macrovascular disease may contribute to increased risk of accelerated cognitive decline in patients with type 2 diabetes. We aimed to determine associations of measures of macrovascular disease with cognitive change in a cognitively healthy older population with type 2 diabetes. RESEARCH DESIGN AND METHODS: Eight hundred thirty-one men and women (aged 60–75 years) attended two waves of the prospective Edinburgh Type 2 Diabetes Study (ET2DS). At baseline, clinical and subclinical macrovascular disease was measured, including cardiovascular event history, carotid intima-media thickness (cIMT), ankle brachial index (ABI), and serum N-terminal probrain natriuretic peptide (NT-proBNP). Seven neuropsychological tests were administered at baseline and after 4 years; scores were combined to a standardized general ability factor (g). Adjustment of follow-up g for baseline g assessed 4-year cognitive change. Adjustment for vocabulary (estimated premorbid ability) was used to estimate lifetime cognitive change. RESULTS: Measures of cognitive decline were significantly associated with stroke, NT-proBNP, ABI, and cIMT, but not with nonstroke vascular events. The association of stroke with increased estimated lifetime cognitive decline (standardized β, −0.12) and of subclinical markers with actual 4-year decline (standardized β, −0.12, 0.12, and −0.15 for NT-proBNP, ABI, and cIMT, respectively) reached the Bonferroni-adjusted level of statistical significance (P < 0.006). Results altered only slightly on adjustment for vascular risk factors. CONCLUSIONS: Stroke and subclinical markers of cardiac stress and generalized atherosclerosis are associated with cognitive decline in older patients with type 2 diabetes. Further investigation into the potential use of subclinical vascular disease markers in predicting cognitive decline is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“According to Feinkohl I. et al., cIMT is also a significant predictor of cognitive decline in patients with T2DM [71].”
From Neuroprotective effect of SGLT2 inhibitors. (2021) · cites this paper as [71]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · Brain and nerve · Cited by 21,038
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Older Adults' Reasons for Using Technology while Aging in Place
Peek, S. T. M., Luijkx, K. G., Rijnaard, M. D., Nieboer, M. E., van der Voort, C. S., Aarts, S., van Hoof, J., Vrijhoef, H. J. M., & Wouters, E. J. M. (2016) · Gerontology · doi:10.1159/000430949 · Cited by 19,690
Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly
Kangas, M., Korpelainen, R., Vikman, I., Nyberg, L., & Jämsä, T. (2015) · Gerontology · doi:10.1159/000362720 · Cited by 18,909
Depression and quality of life in older persons: A review
Sivertsen, H., Bjørkløf, G. H., Engedal, K., Selbæk, G., & Helvik, A.-S. (2015) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000437299 · Cited by 14,152
"General Intelligence," Objectively Determined and Measured
Spearman, C. (1904) · The American Journal of Psychology · doi:10.2307/1412107 · Cited by 6,207
Stern, Y. (2009) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2009.03.004 · Cited by 2,943
Risk of dementia in diabetes mellitus: a systematic review
Biessels, G. J., Staekenborg, S., Brunner, E., Brayne, C., & Scheltens, P. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70284-2 · Cited by 2,187 · cited 1×
“Understanding the role of macrovascular disease in age-related cognitive impairment is particularly important in diabetes, given the higher prevalence of atherosclerotic large vessel disease as well as the accelerated cognitive decline and increased risk of cognitive impairment (5,6) associated with this condition, an…”
Background
Cited by
Biessels, G. J., Strachan, M. W. J., Visseren, F. L. J., Kappelle, L. J., & Whitmer, R. A. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70088-3 · Cited by 551
Self-citationInflammation: the link between comorbidities, genetics, and Alzheimer’s disease
Newcombe, E. A., Camats-Perna, J., Silva, M. L., Valmas, N., Huat, T. J., & Medeiros, R. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1313-3 · Cited by 532
Cognitive function in patients with diabetes mellitus: guidance for daily care
Koekkoek, P. S., Kappelle, L. J., van den Berg, E., Rutten, G. E. H. M., & Biessels, G. J. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70249-2 · Cited by 393
Neuroprotective effect of SGLT2 inhibitors.
Pawlos, A., Broncel, M., Woźniak, E., & Gorzelak-Pabiś, P. (2021) · Molecules · doi:10.3390/molecules26237213 · Cited by 304
Diabetes mellitus and cognitive impairments
Saedi, E., Gheini, M. R., Faiz, F., & Arami, M. A. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i17.412 · Cited by 267
Feinkohl, I., Aung, P. P., Keller, M., Robertson, C. M., Morling, J. R., McLachlan, S., Deary, I. J., Frier, B. M., Strachan, M. W. J., Price, J. F., et al. (2014) · Diabetes Care · doi:10.2337/dc13-1384 · Cited by 266
Self-citationFeinkohl, I., Price, J. F., Strachan, M. W. J., & Frier, B. M. (2015) · Alzheimer's Research & Therapy · doi:10.1186/s13195-015-0130-5 · Cited by 182
Self-citationDiagnostic, Prognostic, and Mechanistic Biomarkers of Diabetes Mellitus-Associated Cognitive Decline
Ehtewish, H., Arredouani, A., & El-Agnaf, O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116144 · Cited by 175
“Moreover, the Edinburgh Type 2 Diabetes Study found that with prior stroke, markers of subclinical macrovascular stress, including higher plasma levels of the natriuretic peptide NT-proBNP, and increased carotid intima-media thickness were associated with a steeper cognitive decline in patients who were diagnosed with…”
BackgroundThe Role of PICALM in Alzheimer’s Disease
Xu, W., Tan, L., & Yu, J. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8878-3 · Cited by 140
Albai, O., Frandeș, M., Timar, R. Z., Roman, D., & Timar, B. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s189905 · Cited by 121
Bedenis, R., Price, A. H., Robertson, C. M., Morling, J. R., Frier, B. M., Strachan, M. W. J., & Price, J. F. (2014) · Diabetes Care · doi:10.2337/dc14-0908 · Cited by 87
Self-citationMayeda, E. R., Karter, A. J., Huang, E. S., Moffet, H. H., Haan, M. N., & Whitmer, R. A. (2014) · Diabetes Care · doi:10.2337/dc13-0215 · Cited by 83
Clark, C. E., Warren, F. C., Boddy, K., McDonagh, S. T. J., Moore, S. F., Goddard, J., Reed, N., Turner, M., Alzamora, M. T., Ramos, R., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15997 · Cited by 78
Self-citationSamaras, K., Lutgers, H. L., Kochan, N. A., Crawford, J. D., Campbell, L. V., Wen, W. X., Slavin, M. J., Baune, B., Lipnicki, D. M., Brodaty, H., et al. (2014) · AGE · doi:10.1007/s11357-013-9613-0 · Cited by 75
McGrath, E. R., Himali, J., Levy, D., Conner, S., Decarli, C., Pase, M., Ninomiya, T., Ohara, T., Courchesne, P., Satizábal, C., et al. (2020) · Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease · doi:10.1161/jaha.119.014659 · Cited by 45
Heath, C. A., Mercer, S. W., & Guthrie, B. (2015) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-309033 · Cited by 52
Prinz, N., Stingl, J., Dapp, A., Denkinger, M. D., Fasching, P., Jehle, P. M., Merger, S. R., Mühldorfer, S., Pieper, U., Schüler, A., et al. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.10.026 · Cited by 54
Biomarkers for cognitive decline in patients with diabetes mellitus: evidence from clinical studies
Zhao, X. Y., Han, Q., Lv, Y., Sun, L., Gang, X., & Wang, G. (2017) · Oncotarget · doi:10.18632/oncotarget.23284 · Cited by 50
Zhang, S., Xue, R., & Hu, R. (2019) · European Journal of Nutrition · doi:10.1007/s00394-019-02078-2 · Cited by 44
Risk factors for cognitive impairment in older people with diabetes: a community-based study
Xiu, S., Liao, Q., Sun, L., & Chan, P. (2019) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018819836640 · Cited by 41
LACY, M. E., Moran, C., Gilsanz, P., Beeri, M. S., Karter, A. J., & Whitmer, R. A. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002557 · Cited by 42
Jensen, M., Zeller, T., Twerenbold, R., & Thomalla, G. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.12926 · Cited by 32
Cardiovascular risk factors and cognitive decline in older people with type 2 diabetes
Feinkohl, I., Keller, M., Robertson, C. M., Morling, J. R., McLachlan, S., Frier, B. M., Deary, I. J., Strachan, M. W. J., & Price, J. F. (2015) · Diabetologia · doi:10.1007/s00125-015-3581-0 · Cited by 34
Self-citationTynkkynen, J., Hernesniemi, J. A., Laatikainen, T. K., Havulinna, A. S., Salo, P. P., Blankenberg, S., Zeller, T., & Salomaa, V. V. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8378-7 · Cited by 31
Gunawan, P. Y., Gunawan, P. A., & Hariyanto, T. I. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01538-1 · Cited by 32
Cardiovascular disease biomarkers are associated with declining renal function in type 2 diabetes
Jenks, S. J., Conway, B. R., McLachlan, S., Teoh, W. L., Williamson, R. M., Webb, D. J., Welsh, P. I., Sattar, N. A., Strachan, M. W. J., & Price, J. F. (2017) · Diabetologia · doi:10.1007/s00125-017-4297-0 · Cited by 25
Self-citationSubclinical carotid atherosclerosis and neurocognitive function in an urban population
Wendell, C. R., Waldstein, S. R., Evans, M. K., & Zonderman, A. B. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.04.009 · Cited by 24
Veugen, M. G. J., Henry, R. M. A., Rocca, H. B., Dagnelie, P. C., Schram, M. T., van Agtmaal, M. J. M., Kallen, C., Sep, S. J. S., van Boxtel, M. P. J., Bekers, O., et al. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311082 · Cited by 25
Bergantin, L. B. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i6.767 · Cited by 23
Diabetic Cognitive Dysfunction: From Bench to Clinic
Zhou, J., Zhang, Z., Zhou, H., & Qian, G. (2020) · Current Medicinal Chemistry · doi:10.2174/1871530319666190206225635 · Cited by 23
Price, A. H., Welsh, P. I., Weir, C. J., Feinkohl, I., Robertson, C. M., Morling, J. R., McLachlan, S., Strachan, M. W. J., Sattar, N. A., & Price, J. F. (2014) · Diabetologia · doi:10.1007/s00125-014-3375-9 · Cited by 22
Self-citationWijsman, L. W., Sabayan, B., van Vliet, P., Trompet, S., de Ruijter, W., Poortvliet, R. K. E., van Peet, P. G., Gussekloo, J., Jukema, J. W., Stott, D. J., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24203 · Cited by 21
Self-citationNew methods for the diagnosis and monitoring of cognitive function in patients with type 2 diabetes
Ciudin, A., & Simó, R. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1024794 · Cited by 20
Subclinical carotid artery atherosclerosis and cognitive function in older adults
Lin, F., Pa, J., Karim, R., Hodis, H. N., Han, S. D., Henderson, V. W., John, J. A. S., & Mack, W. J. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-00997-7 · Cited by 20
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors: Harms or Unexpected Benefits?
Andreea, M. M., Surabhi, S., Popescu, R.-I., Ciobotaru, L. M., Nicolae, C., Emil, T., & Tiberiu, N. I. (2023) · Medicina · doi:10.3390/medicina59040742 · Cited by 19
“[82,83] report that cIMT is also a significant predictor of cognitive decline in T2DM patients.”
BackgroundExpert Consensus on Cognitive Dysfunction in Diabetes
Yang, Y., Zhao, J., & Yu, X. (2022) · Current Medical Science · doi:10.1007/s11596-022-2549-9 · Cited by 18
Vieira, E. R., Mendy, A., Prado, C. M. M., Gasana, J., & Albatineh, A. N. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.08.005 · Cited by 16
“The impact of vascular disease on cognition may not be restricted to localized cerebral small vessel disease or to altered blood flow and ischemic damage, but cognitive decline could also reflect systemic atherosclerotic changes (Feinkohl et al., 2013).”
BackgroundArthritis and Risk of Cognitive and Functional Impairment in Older Mexican Adults
Veeranki, S. P., Downer, B. G., Jupiter, D. C., & Wong, R. (2016) · Journal of Aging and Health · doi:10.1177/0898264316636838 · Cited by 18
“Furthermore, unmeasured confounding, such as other chronic and subclinical diseases, might influence the relationship (L. Y. Chen et al., 2014; de Jongh et al., 2011; Feinkohl et al., 2013; Hadjiev & Mineva, 2010; Wijsman et al., 2013).”
BackgroundÁlvarez‐Bueno, C., Cavero‐Redondo, I., Bruno, R. M., Saz‐Lara, A., Sequí‐Domínguez, I., Notario‐Pacheco, B., & Martínez‐Vizcaíno, V. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.021760 · Cited by 16
“Casado-Naranjo et al., 2016 -0.241 -0.355 -0.126 Del Brutto et al., 2020 -0.228 -0.339 -0.116 Feinkohl et al., 2013 -0.256 -0.375 -0.137 Gatto et al., 2009 -0.265 -0.382 -0.149 Jiang et al., 2016 -0.193 -0.285 -0.101 Komulainen et al., 2007 -0.247 -0.361 -0.134 Lim et al., 2016 -0.251 -0.367 -0.135…”
InfluentialDiabetes and the Nervous System
Zochodne, D. W., & Toth, C. C. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407710-2.00019-9 · Cited by 17
Bertens, A. S., Sabayan, B., de Craen, A. J. M., Van der Mast, R. C., & Gussekloo, J. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-170171 · Cited by 15
Demencia y diabetes: ¿relación casual o causal?
Formiga, F., Reñé, R., & Pérez-Maraver, M. (2014) · Medicina Clínica · doi:10.1016/j.medcli.2014.01.026 · Cited by 17
NT‐proBNP and changes in cognition and global brain structure: The Rotterdam Study
Xiao, T., van der Velpen, I. F., Niessen, W. J., Tilly, M. J., Kavousi, M., Ikram, M. A., Ikram, M. A., & Vernooij, M. W. (2023) · European Journal of Neurology · doi:10.1111/ene.15859 · Cited by 12
Burkauskas, J., Bunevičius, A., Brožaitienė, J., Neverauskas, J., Lang, P., Duwors, R., Mickuvienė, N., & Bunevičius, R. (2017) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acx004 · Cited by 11
A Link Between Brain Insulin Resistance and Cognitive Dysfunctions: Targeting Ca2+/cAMP Signalling
Bergantin, L. B. (2020) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/1871524920666200129121232 · Cited by 12
Wang, X., Li, X., Wang, W., Shi, G., Wu, R., Guo, L., & Lu, C. (2022) · Journal of Diabetes Research · doi:10.1155/2022/9458646 · Cited by 11
“Several possible biological explanations have been proposed, including the indirect effects of diabetes on cognition through subclinical or clinical vascular disease, in that diabetes can cause damage to cerebral microvascular and macrovascular, contributing to cognitive decline [36, 37].”
BackgroundMorelli, N. L., Cachioni, M., Lopes, A., Batistoni, S. S. T., Falcão, D. V. D. S., Neri, A. L., & Yassuda, M. S. (2017) · Dementia & Neuropsychologia · doi:10.1590/1980-57642016dn11-040011 · Cited by 10
Miranda, O., Fan, P., Qi, X., Wang, H., Brannock, D., Kosten, T. R., Ryan, N. D., Kirisci, L., & Wang, L. (2024) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.111066 · Cited by 12
Cognitive dysfunction in diabetes-related foot complications: A cohort study
Nguyen, M., Wong, D. K., Barson, E., Staunton, E., & Fisher, C. A. (2024) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-023-01381-4 · Cited by 11
Association between carotid intima‐media thickness and cognitive decline differs by race
Ferreira, N. V., Bertola, L., Santos, I. S., Goulart, A. C., Bittencourt, M. S., Barreto, S. M., Giatti, L., Caramelli, P., Pereira, A. C., Lotufo, P. A., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.12996 · Cited by 8
Diabetes mellitus tipo 3. ¿El renacer de la insulina inhalada?
Formiga, F., & Pérez-Maraver, M. (2014) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2014.03.001 · Cited by 10
Barzilay, J. I., Younes, N., Pop‐Busui, R., Florez, H. J., Seaquist, E. R., Falck-Ytter, C., & Luchsinger, J. A. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107805 · Cited by 7
Li, Y., Wu, J., Li, W., Gao, X., Dong, W., Xue, X., Hua, X., Zheng, M., & Xu, J. (2023) · Cerebral Cortex · doi:10.1093/cercor/bhad439 · Cited by 6
Cognitive Dysfunction in Diabetes Mellitus
Biessels, G. J., & Ryan, C. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803592-4.00088-2 · Cited by 7
Type 3 diabetes mellitus. The revival of inhaled insulin?
Formiga, F., & Pérez-Maraver, M. (2014) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2014.03.011 · Cited by 6
Dementia and diabetes: Casual or causal relationship?
Formiga, F., Reñé, R., & Pérez-Maraver, M. (2015) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2015.05.015 · Cited by 10
Zhang, W., Ascher, S. B., Dolui, S., Nasrallah, I. M., Lu, Y., Neitzel, J., Toledo, E., Glodzik, L., Shaltout, H. A., Hughes, T. M., et al. (2025) · The Journals of Gerontology Series A · doi:10.1093/gerona/glaf005 · Cited by 4
Chao, H.-Y., Lin, M.-C., Fang, T., Hsu, M.-C., Liang, C., & Lee, M. (2025) · Biomedicines · doi:10.3390/biomedicines13020340 · Cited by 4
“Similar results demonstrated that type 2 diabetes patients with cognitive impairment were associated with a lower ankle–brachial index (ABI) [54,61].”
Cardiovascular Disease and Cognitive Function
Waldstein, S. R., Wendell, C. R., Shaked, D., Hosey, M. M., Seliger, S. L., & Katzel, L. I. (2022) · Springer eBooks · doi:10.1007/978-0-387-85960-6_57 · Cited by 2
Bergman, I., Johansson, K., & Lundberg, C. (2018) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2018.1527292 · Cited by 1
“In a study of individuals with diabetes type 2 and macrovascular disease, cognitive decline at follow-up after four years has been detected (Feinkohl et al., 2013).”
BackgroundCukierman‐Yaffe, T., Lee, S.-F., Paré, G., McQueen, M., Hess, S., & Gerstein, H. C. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215195 · Cited by 1
Diabetes mellitus and its impact on older people
Phillips, A., & Phillips, S. (2017) · Nursing and Residential Care · doi:10.12968/nrec.2017.19.8.446
Diabetes and cognitive decline: Extra care required
Phillips, A. (2018) · Practice Nursing · doi:10.12968/pnur.2018.29.2.76
Potential Risk Factors of the Cognitive Dysfunction in Patients with Type 2 Diabetes Mellitus
Andrei Cristian, B., & Amorin-Remus, P. (2018) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.2478/rjdnmd-2018-0038
“Also in other transversal researches [12,31] and in all prospective probes [18,25] – some results have been negative.”
BackgroundResultInfluentialEndocrine Disease and Cognition
Hedges, D., Farrer, T. J., Bigler, E. D., & Hopkins, R. O. (2019) · Springer eBooks · doi:10.1007/978-3-030-14260-5_8
Frison, É. (2019) · theses.fr (ABES) · doi:10.70675/a527bd03zb814z44e5z8848z942b662a0847 · Cited by 2
Kim, M. J., & Kim, B. (2026) · Biological Research For Nursing · doi:10.1177/10998004261444978
“In addition, micro-and macrovascular complications, including stroke (Chang et al., 2021; Feinkohl et al., 2013; Gong et al., 2021; Yashkin et al., 2018) and impaired central and peripheral vasoregulation (Chung et al., 2015; van den Berg et al., 2009; Xiong et al., 2024), were found to predict…”
Parikh, I. J. (2014) · UKnowledge (University of Kentucky)
Metadata
- Authors
- Feinkohl, I., Keller, M., Robertson, C. M., Morling, J. R., Williamson, R. M., Nee, L. D., McLachlan, S., Sattar, N., Welsh, P., Reynolds, R. M., Russ, T. C., Deary, I. J., Strachan, M. W. J., Price, J. F., & on behalf of the Edinburgh Type 2 Diabetes Study (ET2DS) Investigators
- Affiliations
- University of Edinburgh (GB)
- Centre for Population Health Sciences, University of Edinburgh, Edinburgh, Scotland, United Kingdom
- Western General Hospital (GB)
- University of Glasgow (GB)
- The Queen's Medical Research Institute (GB)
- National Health Service (GB)
- Corresponding author
- Feinkohl, Insa
- Price, Jackie F.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2013-08-13
- Volume
- 36
- Issue
- 9
- Pages
- 2779-2786
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3747922
- OpenAlex
- W2169715537
- Cited by
- 69
- References
- 49
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 5 · 2022: 9 · 2021: 3 · 2020: 5 · 2019: 5 · 2018: 5 · 2017: 6 · 2016: 5 · 2015: 6 · 2014: 11 · 2013: 3
- FWCI
- 5.90
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Funders
- British Heart Foundation (FS/12/62/29889, FS/10/005/28147)
- Medical Research Council (MR/K026992/1)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Keywords
- type 2 diabetes, cognitive decline, macroangiopathy, stroke, carotid intima-media thickness, ankle-brachial index, NT-proBNP, subclinical atherosclerosis, cardiovascular risk, older adults, general intelligence
- MeSH terms
- Aged, Cognition Disorders, Diabetes Mellitus, Type 2, Female, Humans, Male, Middle Aged, Prospective Studies, Biomarkers, Stroke, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
